Multicenter Real World Study of the Evaluation of Traditional Chinese Medicine in the Treatment of Ankylosing Spondylitis

Not Applicable

• Conditions: Ankylosing spondylitis

• Registration Number: ITMCTR2200005889
• Lead Sponsor: China Academy of Chinese Medical Sciences Guanganmen Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Patients in the active phase of ankylosing spondylitis (ASDAS-CRP=1.3) who meet the Western diagnostic criteria
? Meet the diagnostic criteria of Chinese medicine evidence of ankylosing spondylitis
? Age 18~65 years old.
? Those who voluntarily participated in the clinical study and agreed to sign the informed consent form.

Exclusion Criteria

?Those who underwent AS surgery/acupuncture treatment.
?Patients with other rheumatic immune diseases, such as rheumatoid Arthritis, sjogren syndrome et al.
?Patients with advanced disease spinal ankylosis, severe joint deformity.
?Patients with severe primary diseases such as combined tumor, severe cardiac, cerebrovascular, renal disease, liver and kidney insufficiency.
?Patients with poorly controlled blood pressure, blood glucose and blood lipids.

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein;

Secondary Outcome Measures

Name	Time	Method
depression-anxiety-stress patients emotional self-rating scale;Bath Ankylosing Spondylitis Disease activity Index;Work Efficiency and Activity Impact Questionnaire;Bath Ankylosing Spondylitis functional Index;Bath Ankylosing Spondylitis Metrological Index;Assessment of Spondyloarthritis International Society-Health Index;Facit-fatigue Scale for treatment of Chronic Diseases;